t e C h n I C a l r e p O r t S Pericytes and smooth muscle cells are integral components of the brain microvasculature. However, no techniques exist to unambiguously identify these cell types, greatly limiting their investigation in vivo. Here we show that the fluorescent Nissl dye NeuroTrace 500/525 labels brain pericytes with specificity, allowing high-resolution optical imaging in the live mouse. We demonstrate that capillary pericytes are a population of mural cells with distinct morphological, molecular and functional features that do not overlap with precapillary or arteriolar smooth muscle actin-expressing cells. The remarkable specificity for dye uptake suggests that pericytes have molecular transport mechanisms not present in other brain cells. We demonstrate feasibility of longitudinal pericyte imaging during microvascular development and aging and in models of brain ischemia and Alzheimer's disease. The ability to easily label pericytes in any mouse model opens the possibility of a broad range of investigations of mural cells in vascular development, neurovascular coupling and neuropathology.
Microvascular smooth muscle cells (SMCs) and pericytes play fundamental roles in the development and maintenance of the brain's vascular network and the blood-brain barrier, signaling within the neurovascular unit, and modulation of microregional cerebral blood flow [1] [2] [3] [4] [5] [6] [7] and have been implicated in many neuropathological processes 2, 8, 9 . However, precise investigation has been greatly limited by the inability to unambiguously differentiate among the different subtypes of vascular mural cells because they share many protein markers and have heterogeneous morphology, with ambiguous boundaries at the transition between precapillary arterioles and capillaries 7,10-13 . Thus, even though these cells can be broadly grouped into two distinct categories, one type with ring-like morphology and expression of the contractile protein α-smooth muscle actin (α-SMA) and another type with long, thin processes and no α-SMA, there is still considerable debate about the extent to which these are different cell types with different functions 2, 7, [10] [11] [12] [13] [14] [15] [16] [17] . Development of new tools that allow unambiguous separation of these cells during in vivo imaging would greatly enhance the ability to study the physiology and pathology of the neurovascular unit.
We have discovered that a commercially available small molecule fluorescent dye, a fluoro-Nissl green 18 derivative called NeuroTrace 500/525, exclusively and efficiently labels capillary pericytes in the live brain upon topical application or intracortical microinjection. Using transgenic reporter mice and dynamic imaging of spontaneous vasomotility in awake mice, we demonstrate that this dye specifically labels noncontractile vascular mural cells embedded in two layers of basal lamina that have long, thin processes spanning multiple vessel branches and lack α-SMA expression. In contrast, adjacent contractile α-SMA-expressing vascular mural cells with ring-like morphology are not labeled with this dye, strongly suggesting that these cells constitute distinct and non-overlapping populations.
We demonstrate the use of this dye for dynamic imaging in models of cerebral ischemia, aging and Alzheimer's disease and during early postnatal brain microvascular development. Thus, we provide, to our knowledge, the first method for exclusive identification and in vivo imaging of capillary pericytes in the healthy and diseased brain. This method can be applied immediately, without the need for transgenic reporter mice, and is likely to have broad applications in many fields of research, including development and pathology of the neurovascular unit, neurovascular coupling and neurodegeneration. In addition, the robust and selective dye labeling may allow specific pericyte isolation for gene expression and proteomic studies. It also raises questions regarding the possible expression of distinct molecular transport mechanisms in pericytes that explain their selective dye uptake.
RESULTS
Specific and robust dye labeling of capillary pericytes in the live mouse brain As we were screening various dyes for differential properties of cell labeling in the live mouse brain, we noticed that a fluorescent Nissl 18 derivative with affinity for Nissl bodies, NeuroTrace 500/525 (but not other NeuroTrace variants), commonly used to label neurons in fixed tissues, had unusual properties when applied to the mouse brain in vivo. Instead of neuronal labeling as expected, topical application of this dye through a cranial window led to labeling of a distinct population of cells lining cerebral blood vessels up to 400 µm deep in the cortex ( Fig. 1a and Supplementary Video 1). Labeled cells lined the smallest cerebral vessels and had the morphology of capillary pericytes 7, 13 , with multiple slender processes extending longitudinally and spanning several vessel branches ( Fig. 1) . Dye labeling was very bright and concentrated both in cell soma and throughout the processes, where it displayed a punctate pattern ( Fig. 1a,b) . Pericyte labeling remained t e C h n I C a l r e p O r t S strong over 2-3 d and by day 4 had mostly disappeared. Notably, we did not observe any signs of cellular toxicity as a result of the dye administration and subsequent imaging as evidenced by the lack of changes in cellular morphology over intervals up to 3 d.
Surprisingly, no other parenchymal brain cell type was labeled at all (some meningeal and perivascular macrophages at the site of topical dye application were transiently labeled). Colabeling with the fluorescent dye sulforhodamine 101 (SR101), which labels astrocytes and oligodendrocytes 19, 20 , showed no colocalization, confirming that neither of these cell types is labeled by NeuroTrace 500/525 ( Fig. 1b) . To precisely determine the identity of the labeled cells, we applied the dye to the cortex of transgenic mice with fluorescent protein labeling of all vascular mural cells, initiated by Cre recombinase expression driven by the promoter of the beta receptor for platelet-derived growth factor (Pdgfrb-cre:Tomato mice) 13, 21 , which showed 99 ± 1% (mean ± s.d.) colocalization between Pdgfrb antibody-stained cells and genetically labeled Tomato-expressing cells ( Supplementary Fig. 1 , n = 3 mice, 948 Pdgfrb + cells and 957 Tomato + cells). NeuroTrace dye labeling colocalized specifically with fusiform capillary pericytes (99 ± 0.1% of all NeuroTrace-labeled cells were colabeled with Tomato in vivo, n = 3 mice, 305 NeuroTrace + Tomato + cells and 307 NeuroTrace + cells) and not with ring-like precapillary or arteriolar SMCs (Fig. 2) . We also confirmed that NeuroTrace was exclusive to vascular pericytes in a separate commonly used transgenic mouse line with labeling in vascular mural cells and cells of the oligodendrocyte lineage, initiated by Cre expression driven by the Cspg4 (designated here as NG2) chondroitin sulfate proteoglycan promoter (NG2-cre:Tomato) 7, 13, 22, 23 . Again, dye labeling was found specifically in fusiform capillary pericytes and not in ring-like precapillary or arteriolar SMCs nor in NG2 + glia or oligodendrocytes ( Fig. 3) . Discrete transition points from dye-negative SMCs to dye-labeled pericytes were clearly observed ( Fig. 3a) . In the NG2-cre mouse line not all pericytes are labeled due to incomplete Cre recombination 13, 22 , in contrast to NeuroTrace, which provided complete labeling of all pericytes in the dye-labeled brain region ( Fig. 3c,d) .
To further confirm that the NeuroTrace-labeled cells were indeed pericytes embedded in the basal lamina 2 , we performed high-resolution confocal imaging with deconvolution, observing collagen IV basal lamina antibody staining surrounding cells labeled with NeuroTrace and Pdgfrb-cre:Tomato ( Fig. 4 and Supplementary Fig. 2) . t e C h n I C a l r e p O r t S This approach allowed direct visualization of the two layers of the basal lamina with molecular specificity. All Pdgfrb-cre:Tomato cells with capillary pericyte morphology were embedded in the collagen IV-labeled basal lamina ( Fig. 4a,b ). During immunostaining, NeuroTrace dye diffuses out of pericytes that are labeled through in vivo cortical dye application. Thus, we had to perform sequential imaging of the same cell before and after immunostaining to directly detect dual basal lamina surrounding cells that had previously been labeled with NeuroTrace. All cells that were labeled with NeuroTrace and sequentially imaged in this manner displayed robust two-layer collagen IV-labeled basal lamina ( Fig. 4c and Supplementary Fig. 2 , n = 11 cells).
To provide further evidence of this cellular localization, we attempted to photo-oxidize NeuroTrace for diaminobenzidine (DAB) detection at the ultrastructural level ( Fig. 4d) . Photo-oxidation is known to have heterogeneous success rates for different dyes 24, 25 , and we had some limited success ( Fig. 4d ) at detecting the DAB signal in pericytes using transmission electron microscopy. Reasons for the heterogeneity could be poor photo-oxidative reactivity of the dye, as has been shown for other dyes 24, 25 . Nonetheless, this combination of approaches allowed us to conclusively demonstrate that NeuroTrace-labeled cells are indeed embedded in two layers of basal lamina, further confirming that they are indeed capillary pericytes ( Fig. 4 and Supplementary Fig. 2 ) There are two potential routes for the NeuroTrace dye to enter the brain: directly through the glia limitans into the interstitial space 26 or via diffusion through the perivascular Virchow-Robbins space. The second route has the potential to result in predominant labeling of pericytes given their perivascular location. Thus, to bypass these barriers and test whether the dye specifically labels pericytes regardless of entry route, we directly microinjected NeuroTrace into the parenchyma through a pulled glass capillary ( Supplementary  Fig. 3a) . Two-photon time-lapse imaging during dye injection revealed exclusive pericyte labeling within minutes, with no labeling of other cell types (Supplementary Fig. 3a-c and Supplementary Video 2). Thus, the specificity of labeling is likely due to an intrinsic property of capillary pericytes that is absent from any other brain cell, including the immediately adjacent perivascular SMCs. This specificity, combined with the robust labeling brightness and persistence over days, makes the use of this dye, to our knowledge, the first method to unambiguously image and distinguish capillary pericytes from all other brain cells in vivo.
NeuroTrace-labeled pericytes do not exhibit spontaneous contractility Neurovascular coupling is a critical brain homeostatic function that is controlled by complex interactions between cells of the neurovascular unit 9 . There is ongoing debate as to which subsets of mural cells are ultimately responsible for vascular dilation and contraction and whether there are subsets of capillary pericytes capable of mediating vasomotility 7, 10, 13 . Resolving this controversy is critical for our understanding of neurovascular coupling and blood flow control. To determine whether NeuroTrace-labeled pericytes are present on vessels that exhibit active vasomotility, we performed in vivo imaging in transgenic mice with mCherry labeling of SMCs expressing smooth muscle actin (Acta2 gene promoter, designated here as SMA) (SMA-mCherry) 7, 27 (Fig. 5) . NeuroTrace exclusively labeled mural cells that did not express mCherry on vessels ranging in diameter from 2.3 to 13.7 µm (average 5.3 ± 2.2 µm, 104 vessel locations from n = 5 mice) ( Fig. 5c) . SMA-mCherry-covered vessels that were not labeled with NeuroTrace had a range of diameters from 2.9 to 29.9 µm (average 9.6 ± 4.7 µm, 115 vessel locations from n = 5 mice) ( Fig. 5c) . Consistent with the results in Pdgfrb-cre:Tomato and NG2-cre:Tomato mice ( Fig. 2  and Fig. 3 ), NeuroTrace was able to precisely highlight transition points from completely unlabeled SMCs to strongly labeled pericytes ( Fig. 5b and Fig. 6a ). Furthermore, consistent with SMA-mCherry labeling, the arteriole-specific dye 633-hydrazide 28 exclusively labeled vessels that were not labeled with NeuroTrace ( Fig. 5d) , providing further evidence of the existence of two distinct populations of mural cells, α-SMA-expressing SMCs on arterioles and NeuroTrace-labeled pericytes on capillaries.
To determine whether these two populations of cells exhibit different functions, we performed in vivo time lapse imaging of spontaneous vasomotion in awake and anesthetized mice. As was recently shown 7,14 , spontaneous vasomotility was found exclusively in SMC-but not pericyte-covered vessels as based on a measure that accounts for amplitude, frequency and duration of diameter changes, termed vasomotility index 7 (see Online Methods) ( Fig. 6) . Thus, NeuroTrace specifically labels noncontractile capillary pericytes and does not label contractile precapillary and arteriolar α-SMA-expressing mural cells. Therefore, NeuroTrace provides a new method for in vivo investigations of differential mural cell physiology during neurovascular coupling and potentially during pathological processes.
Intravital imaging of pericytes during development and aging, in cerebral ischemia, and in Alzheimer's models A major challenge for determination of capillary pericyte function in aging and neuropathological conditions has been the lack of methods for precise identification and visualization during in vivo experimentation. Therefore, we explored whether NeuroTrace labeling could t e C h n I C a l r e p O r t S be used in a range of conditions in which pericyte dysfunction has been implicated. First, NeuroTrace labeling in early postnatal stages, adult and aged 29-month-old wild-type mice revealed brightly labeled pericytes with no significant differences in dye labeling quality or distribution among postnatal day (P) 10, P60 and P870 mice (Fig. 7a,b ) (P10: 3,388 ± 769 cells/mm 3 , P60: 2,860 ± 166 cells/mm 3 , P870: 3,245 ± 317 cells/mm 3 , n = 3 mice per group, two-way ANOVA, Bonferroni post-test). In addition to quantifying cell density, we also observed dye-labeled pericyte cell bodies and processes not associated with perfused vessels (Fig. 7c,d) . These cells were more prevalent in P10 mice than in P60 and P870, likely due to pericyte association with unperfused vascular sprouts [29] [30] [31] (P10: 173 ± 91 cells/mm 3 , P60: 24 ± 28 cells/mm 3 , P870: 28 ± 36 cells/mm 3 , n = 3 mice per group, twoway ANOVA, Bonferroni post-test). Notably, however, pericytes bridging regions with no evident perfused vessels were also found in adult and aged mice, when most vascular structural plasticity has ended (Fig. 7d,e ), suggesting potential signaling functions of these bridging cells and/or permanent remnants of developmental vascular pruning. t e C h n I C a l r e p O r t S Thus, NeuroTrace can be used for pericyte labeling to determine in vivo cell-cell interactions during development of the neurovascular unit and to test age-related mural cell-associated vascular dysfunction in any wild-type or transgenic mouse model. Fig. 4a ). This model, which has been previously characterized, allows dynamic imaging during the initial stages of ischemia. This is a time when cortical spreading depolarization, a known modulator of SMC contractility, is highly prevalent and early changes in vascular and neuronal pathology occur 32 . Five minutes of bilateral carotid occlusion caused marked reduction in cerebral blood flow and resulted in reversible collapse or constriction of vessels specifically covered by α-SMA-expressing SMCs (−56 ± 14.7% change in diameter, 23 vessel locations from n = 3 mice) ( Supplementary Fig. 4b-e ). In contrast, NeuroTrace-labeled pericyte-covered capillaries displayed decreased or stalled blood flow but did not exhibit significant changes in diameter (−3 ± 1.4% change in diameter, 28 vessel locations from n = 3 mice (Supplementary Fig. 4b-e ). Thus, it appears that only α-SMApositive but not NeuroTrace-labeled cells contract appreciably during Finally, as smooth muscle cells and pericytes have been implicated in the pathogenesis of Alzheimer's disease 8, 9 , we visualized pericytes in a mouse model of this disease (5xFAD mice). Amyloid plaques and cerebral amyloid angiopathy were labeled with the amyloid-binding dye thioflavin S (Fig. 8a,b) . Consistent with our finding in aged wild-type mice, NeuroTrace labeling in 5xFAD mice was similar to that in wild-type aged matched controls (Fig. 8c) (wild-type: 2,999 ± 254 cells/mm 3 , 5xFAD: 2,982 ± 162 cells/mm 3 , n = 3 mice per group, P = 0.947, t-test). Furthermore, we did not detect NeuroTrace labeling on vessels that exhibited cerebral amyloid angiopathy (Fig. 8a,b) , suggesting that overt amyloid aggregation may be exclusive to α-SMCcovered arterioles in these mice. However, both of these markers label other cell types, and there are no known exclusive genetic markers of pericytes, prohibiting their unambiguous separation from other vascular mural cells. Even currently available dual-reporter, triple-transgenic mice cannot exclusively label pericytes 7 . Thus the identification of a capillary-pericyte-specific marker is crucial for future studies. To our knowledge, NeuroTrace labeling provides the first method for unambiguous in vivo identification of brain capillary pericytes as distinguished from all other brain cells. NeuroTrace is easy to use during intravital imaging, it robustly and brightly labels capillary pericytes embedded in the vascular basal lamina, and it can be used for repeated imaging of these cells without acute evidence of toxicity. This method can now be implemented in vivo for broad interrogation of pericyte function throughout development and into advanced aging and in numerous models of brain pathology. NeuroTrace exclusively labels capillary pericytes, which are cells with long processes that do not fully wrap around vessels, in contrast to immediately upstream precapillary and arteriolar ring-like mural cells.
Next we visualized pericytes in a model of transient ischemia via reversible bilateral common carotid artery occlusion (Supplementary
The specific nature of dye labeling to capillary pericytes, combined with the fact that these cells have a unique morphology, do not express α-SMA and are not contractile, provides a strong line of evidence that pericytes are a discrete cell population that is distinct from immediately adjacent SMCs and that there are no transitional precapillary cells with hybrid properties. Furthermore, the exclusivity of dye uptake suggests a distinct molecular mechanism unique to brain capillary pericytes, opening the possibility of future specific molecular targeting of pericytes for therapeutic purposes.
The precise role of capillary pericytes in neurovascular coupling is debated 7, 10, 11, 14 . Under anesthetized and awake conditions, we found no evidence of spontaneous changes in vessel diameter on vessels covered by NeuroTrace labeled pericytes. This was in contrast to immediately upstream vessels covered by α-SMA-expressing SMCs, which exhibited robust spontaneous changes in diameter. These data provide further independent evidence that these two populations of mural cells are indeed functionally, molecularly and morphologically distinct, with clear delineations at the transition point from contractile α-SMA-expressing SMCs to non-contractile pericytes. Our findings are consistent with previous studies showing no significant changes in vessel diameter at the capillary level after sensory stimulation 7, 11, 14, 33 . Pericyte dysfunction has been implicated in several neuropathological states, including brain ischemia and Alzheimer's disease [8] [9] [10] 12, 37 . The inability to precisely identify pericytes in previous studies has limited the in vivo investigation of distinct contributions of different mural cell types to these diseases. The differences in our results compared to previous studies regarding pericyte changes in aging and Alzheimer's disease models are unclear. However, one possibility is that previous studies have generally pooled both SMCs and pericytes in their quantifications. Given the known presence of amyloid accumulation in arterioles, SMCs might be more vulnerable to age-related changes than capillary pericytes.
NeuroTrace labeling now provides a rapidly adoptable method to exclusively label capillary pericytes in aged wild-type and transgenic mouse models and potentially in other species. This tool will facilitate future investigations of pericyte contributions to normal brain function and pathology.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. 
